Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships

University of Ottawa

$70,000.00

Gating Deficiency in Schizophrenia: Nicotinic Treatment Effects and Clinical and Neural Correlates

FY 2012-13

Summary
People who are diagnosed with schizophrenia tend to have difficulties with attention and concentration. Studies found that patients with schizophrenia are unable to block out or filter irrelevant, distracting information (e.g., noises). This may lead to overloading the brain and may worsen symptoms like hallucinations and delusions. The ability to filter sensory information has been linked to a gene that affects the way nicotine acts in the brain. 60-90% of patients with schizophrenia are cigarette smokers compared to 25% of the general population. Some experts suggested that patients with schizophrenia may use nicotine to improve the ability of the brain to block or filter out distracting information. Also, brain imaging studies revealed reductions in brain regions that may lead to hallucinations and brain dysfunctions. One method of laboratory research examined brain electrical activity (EEG) in response to sounds and has been useful in our attempt to understand this gating problem in schizophrenia. The present study uses EEG measures and brain imaging to achieve these goals: 1) to determine how patients with schizophrenia differ from non-patients in their response to sounds; 2) to see whether gating defects are related to both the subjective experiences and the EEG activity associated with hallucinations; 3) to find out the effects of novel nicotine-like drug treatment on gating and hallucinations; 4) to look at reduced brain regions and how they might affect gating and response to treatment. The study will also compare those with and without the nicotine regulating gene. This research will improve our understanding of the way in which schizophrenia patients process information in their environment and how smoking/nicotine affects their attention and concentration. We hope that the nicotine-like treatment will help improve attention and concentration deficits to ameliorate the lives of those suffering from schizophrenia and their families.
Program
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
283802
Name
Choueiry Joelle
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Clinical
Prcname2
Doctoral Research Awards - A
Projecttitle
Gating Deficiency in Schizophrenia: Nicotinic Treatment Effects and Clinical and Neural Correlates
Programtype2
Studentship Programs
Orgnameinp2
University of Ottawa
Cihramount2
$70,000
Cihrequipment2
$0
Programname2
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Keyworddelim
Alpha 7 Nicotinic Receptor Gene; Electroencephalography; Event Related Potentials; Nicotinic Receptor Agonist And Positive Allosteric Modulator; Nicotinic Receptors; Psycho-Pharmacology; Schizophrenia; Sensory Gating; Sensory Memory
Abstract
People who are diagnosed with schizophrenia tend to have difficulties with attention and concentration. Studies found that patients with schizophrenia are unable to block out or filter irrelevant, distracting information (e.g., noises). This may lead to overloading the brain and may worsen symptoms like hallucinations and delusions. The ability to filter sensory information has been linked to a gene that affects the way nicotine acts in the brain. 60-90% of patients with schizophrenia are cigarette smokers compared to 25% of the general population. Some experts suggested that patients with schizophrenia may use nicotine to improve the ability of the brain to block or filter out distracting information. Also, brain imaging studies revealed reductions in brain regions that may lead to hallucinations and brain dysfunctions. One method of laboratory research examined brain electrical activity (EEG) in response to sounds and has been useful in our attempt to understand this gating problem in schizophrenia. The present study uses EEG measures and brain imaging to achieve these goals: 1) to determine how patients with schizophrenia differ from non-patients in their response to sounds; 2) to see whether gating defects are related to both the subjective experiences and the EEG activity associated with hallucinations; 3) to find out the effects of novel nicotine-like drug treatment on gating and hallucinations; 4) to look at reduced brain regions and how they might affect gating and response to treatment. The study will also compare those with and without the nicotine regulating gene. This research will improve our understanding of the way in which schizophrenia patients process information in their environment and how smoking/nicotine affects their attention and concentration. We hope that the nicotine-like treatment will help improve attention and concentration deficits to ameliorate the lives of those suffering from schizophrenia and their families.
Competitiondate
201210
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Choueiry, Joelle
Approvedterm
2 ans 0 mois
Cihrcontribution2
~ $70,000~ $0~
University of Ottawa - $70,000 Grant (2012-13) | Canada Spends